ClearRead Xray Pneumothorax

by Riverain Technologies  · Based in United States → — See Clearly. Decide Confidently.™ Streamline reading time, improve accuracy, and quantify population health metrics in cardiothoracic imaging.
Critical Care Emergency Medicine Radiology

Regulatory Status Disclosed

Overview

ClearRead Xray Pneumothorax: AI-Driven Detection for Chest X-rays

ClearRead Xray Pneumothorax is an AI-powered medical imaging software developed by Riverain Technologies. It is designed to enhance the interpretation of adult upright and portable chest X-rays by providing a triage notification for suspected pneumothorax of 5mm or larger. This tool aims to improve the efficiency and accuracy of radiologists in detecting this life-threatening emergency. Part of the broader ClearRead Xray suite, it leverages unique suppression technology to provide an unimpaired view of the chest, revealing actionable data for cardiothoracic diseases. The solution integrates seamlessly into existing PACS/workstation workflows without requiring additional radiation dose or changes to current imaging protocols.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Triage notification for suspected pneumothorax (5mm or larger)
  • 92% Sensitivity, 95% Specificity for pneumothorax detection
  • Works on all adult upright and portable chest X-ray devices
  • Integrates into existing PACS/workstation workflows via DICOM protocol
  • AI-driven analysis of digital frontal chest radiographs
  • No additional radiation dose or changes to existing imaging protocols
  • Part of the broader ClearRead Xray suite (includes bone suppression, nodule detection, enhancement)

Use Cases

  • Prioritizing chest X-rays for radiologist review
  • Early detection of pneumothorax in emergency settings
  • Improving radiologist efficiency and accuracy in chest X-ray interpretation
  • Supporting diagnosis of cardiothoracic diseases

What Physicians Need to Know

DICOM Support & Standards
ClearRead Xray Pneumothorax receives and delivers images and information via DICOM protocol over a standard IEEE 802.3 network connection.
PACS Integration Method
ClearRead Xray Pneumothorax integrates with existing PACS review stations, eliminating the need for dedicated workstations. The integration is designed to allow ClearRead results to be incorporated into existing PACS, EHR, and reporting workflows.
Reading Room Workflow Impact
The tool is designed to be workflow-friendly, increasing reading efficiency and improving nodule detection accuracy. It provides triage notification for potential pneumothorax cases 5mm or larger. The system sends 'nodule-only' images back into the PACS, allowing radiologists to review them side-by-side with original images using specific hanging protocols. This integration aims to reduce cognitive burden and support more confident decisions.
AI Model Architecture (deep learning approach)
ClearRead Xray Pneumothorax utilizes advanced AI algorithms. The models were trained using clinically validated negative cases and cases with digitally inserted synthetic pneumothoraces, as well as real cases with ground truth established by clinical experts, including publicly available data from NIH.
Processing Speed (per study)
ClearRead images process quickly within minutes.
FDA Clearance Pathway (510k/De Novo)
ClearRead Xray Pneumothorax received 510(k) clearance from the FDA on March 10, 2022.
Supported Modalities (CT/MRI/X-ray/US)
ClearRead Xray Pneumothorax is designed for chest X-rays.
Sensitivity & Specificity Data
Clinical evaluation validated the efficacy of ClearRead Xray Pneumothorax for workflow prioritization of X-ray images containing a suspected pneumothorax, with performance measured by the AUC of the ROC curve. For nodule detection (part of the ClearRead Xray suite), studies have shown improved detection rates.
RSNA/ACR Validation
Riverain Technologies presents research at RSNA. For example, a University of Washington study on ClearRead CT was presented at RSNA 2024.
Physician Tip

ClearRead Xray Pneumothorax is a computer-assisted triaging tool designed to prioritize chest X-rays based on the suspected presence of pneumothorax (5mm or larger). It provides adjunctive information and is not intended for diagnosis. The tool can help radiologists by providing an unimpaired view of the chest, potentially improving the detection of subtle findings and reducing reading times. It integrates into existing PACS workflows, allowing for side-by-side review of original and processed images.

ClearRead Xray Pneumothorax integrates with existing PACS and can be deployed enterprise-wide. Riverain Technologies has expanded access to its ClearRead Chest suite (which includes ClearRead Xray Pneumothorax) through integration with RapidAI's Rapid Enterprise Platform, allowing for a unified enterprise workflow across PACS, EHR, and reporting systems.

Details

Category Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Unknown
Mobile AppNo
API Available No
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Critical Care, Emergency Medicine, Radiology

What the Web Says

ClearRead Xray Pneumothorax is an AI-powered triage tool designed to identify suspected pneumothorax (5mm or larger) on adult chest X-rays, aiming to prioritize cases for radiologist review and improve efficiency. It is part of Riverain Technologies' ClearRead Xray suite, which also includes bone suppression and nodule detection capabilities. The device is intended to provide adjunctive information and notification, not for definitive diagnosis, and does not replace review by trained professionals.

Overall: Positive

Strengths

  • Aids in prioritization and triage of time-sensitive findings, potentially leading to earlier identification and improved patient care.
  • Demonstrated high accuracy in detecting pneumothorax and tension pneumothorax in a study, with AUCs of 0.979 and 0.987 respectively.
  • Integrates with existing PACS and workstations, eliminating the need for dedicated hardware and maintaining workflow.
  • Can improve radiologist efficiency and reduce cognitive burden by highlighting potential pneumothorax cases.
  • Utilizes AI algorithms to analyze images for features suggestive of pneumothorax.
  • FDA-cleared as a Class II medical device.

Limitations

  • Not intended for diagnostic use; it is a notification-only triage tool.
  • Does not replace the need for review and diagnosis by trained professionals.
  • Limited to adult, digital frontal chest radiographs and requires both lungs to be in the field of view.
  • No specific reviews found on G2, Capterra, or Reddit for this particular product from Riverain Technologies.
  • Some general feedback about Riverain Technologies mentions a lack of management transparency and a high-pressure work environment.

Based on reviews from: fda.report, fda.gov, medrxiv.org, surgi-plan.com, aihealthindex.io, riveraintech.com, rapidai.com, theimagingwire.com, physicianaitools.com, parikhradiology.com, nih.gov, innolitics.com, terarecon.com

Last updated: 2026-10-31

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate ClearRead Xray Pneumothorax

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

riveraintech.com
Riverain Technologies Brings ClearRead AI-Powered Lung Cancer Detection to Hospitals and VA Medical Centers
Riverain Technologies announced significant growth in 2023, including a 286% increase and 30 new customers, with its ClearRead technology being adopted by numerous healthcare organizations, Department of Defense facilities, and VA medical centers. The company also announced the full commercial release of ClearRead Xray Pneumothorax.
2024-02
riveraintech.com
Riverain Technologies Announces Significant Growth and Milestones in 2023
Riverain Technologies reported substantial growth in 2023, expanding its customer base and achieving key milestones, including the full commercial release of ClearRead Xray Pneumothorax. The company's AI-driven imaging technology is being utilized in various healthcare settings, including military and VA medical centers.
2024-02
riveraintech.com
Riverain Technologies Expands ClearRead Xray with Pneumothorax Detection
Riverain Technologies announced the FDA clearance and MDR approval of ClearRead Xray Pneumothorax, a new application designed to assist in the early detection of pneumothorax. This computer-assisted tool aims to alert readers to the suspected presence of pneumothorax, which can be challenging to identify in its subtle stages.
2023-07
theimagingwire.com
Riverain's Pneumothorax FDA Clearance
Riverain Technologies received FDA clearance for its new ClearRead Xray Pneumothorax solution, expanding its focus from lung nodule and cancer detection to include pneumothorax detection. This move is seen as a natural extension of their expertise in thoracic imaging.
2022-04
fda.gov
510(k) Premarket Notification - ClearRead Xray Pneumothorax
The FDA granted 510(k) clearance for ClearRead Xray Pneumothorax, a computer-assisted triaging tool designed to prioritize chest X-rays based on the suspected presence of a pneumothorax 5mm or larger. The device analyzes images using an AI algorithm and provides case-level output for worklist prioritization.
2022-03
riveraintech.com
ClearRead Xray Cardiothoracic AI Suite
The ClearRead Xray cardiothoracic AI suite includes ClearRead Xray Pneumothorax, which is designed for early detection of pneumothorax. The suite aims to improve reading efficiency and accuracy in chest X-ray interpretation.
unknown

Videos

Product demos, reviews, and walkthroughs for ClearRead Xray Pneumothorax.

View all on YouTube

Frequently Asked Questions

ClearRead Xray Pneumothorax is a computer-assisted triage tool that uses an artificial intelligence algorithm to analyze chest X-ray images for features suggestive of a pneumothorax 5mm or larger. It provides a triage notification for potential pneumothorax cases, helping to prioritize chest X-rays for urgent review.
ClearRead Xray Pneumothorax has received FDA 510(k) clearance and is approved under Medical Device Reporting (MDR) for international markets.
The system is designed to operate in parallel to and independently of standard image interpretation workflows. It receives images via DICOM protocol and makes case-level output available to a PACS/workstation for worklist prioritization or triage, without requiring a separate application viewer or login.
ClearRead Xray Pneumothorax is intended as an adjunctive tool and is not for diagnostic use beyond notification. It should not be used in lieu of a full patient evaluation or relied upon to make or confirm diagnoses, nor does it replace the review and diagnosis of X-rays by trained professionals. It is also limited to analyzing pneumothoraces 5mm or larger and requires both lungs to be in the field of view.
Yes, other AI solutions exist for pneumothorax detection on X-rays. For example, Aidoc has an FDA 510(k) cleared solution for triage and notification of pneumothorax on X-ray exams.
ClearRead Xray Pneumothorax is intended as a computer-assisted triaging tool to prioritize chest X-rays based on the suspected presence of a pneumothorax 5mm or larger. It provides adjunctive information to aid in the urgency of adult chest X-ray image review.

Related Tools

Perimeter Medical Imaging AI
Perimeter Medical Imaging AI
Clinical Decision Support & Reference
The Claire OCT System by Perimeter Medical Imaging AI uses Optical Coherence Tomography and AI to provide real-time, high-resolution tissue imaging during surgery to help identify cancerous tissue.
SOPHiA DDM
SOPHiA GENETICS
Oncology AI
SOPHiA DDM™ is an AI-driven and cloud-powered platform that helps clinicians generate real-time, actionable insights for patients with cancer and rare disorders by analyzing complex genomic, radiomic, and multimodal data.
Qure.ai QXR
Qure.ai
Clinical Decision Support & Reference
Qure.ai QXR is an AI-powered solution for chest X-ray interpretation, designed to assist radiologists, pulmonologists, and ER physicians in diagnosing various conditions.
DeepBio DeepDx® Prostate
DeepBio
Oncology AI
DeepDx® Prostate leverages deep learning to standardize prostate cancer diagnostics by detecting abnormalities in digital slides with high precision, providing automated Gleason grading, tumor quantification, and tumor length measurements.
CortiCare (Virtual EEG Department)
CortiCare
Neurology AI
CortiCare offers 24/7 remote EEG monitoring and interpretation services, functioning as a virtual EEG department to assist hospitals and neurology practices in identifying seizures and other neurological conditions.
AI Highlights
CapsoVision
Gastroenterology AI
AI Highlights is an AI-assisted reading tool for the CapsoCam Plus capsule endoscopy system, designed to reduce the time physicians spend reviewing small bowel capsule endoscopy studies by identifying and prioritizing images with suspected abnormal lesions.

See all Radiology & Imaging AI tools →

More from Riverain Technologies

CLEARREAD +CONFIRM
RIVERAIN TECHNOLOGIES
Radiology & Imaging AI
CLEARREAD +CONFIRM is an AI tool by Riverain Technologies that enhances chest X-ray images to improve the visibility and confirmation of lines and tubes, reducing reading time by approximately 19% for radiologists.
ClearRead CT
RIVERAIN TECHNOLOGIES
Cardiology AI
ClearRead CT is an FDA-cleared AI suite by Riverain Technologies for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology.
ClearRead CT CAC
Riverain Technologies
Cardiology AI
ClearRead CT CAC by Riverain Technologies is an AI-powered software that enables opportunistic screening for coronary artery calcification (CAC) by accurately detecting, quantifying, and reporting Agatston scores from routine, ungated, non-contrast chest CT scans.
DELTAVIEW MODEL
Riverain Technologies
Oncology AI
DELTAVIEW MODEL, by Riverain Technologies (formerly Riverain Medical Group), is an AI-driven medical imaging software for temporal comparison of chest X-rays, designed to detect subtle changes like early-stage lung cancer nodules through bone suppression and image subtraction technology.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.